How India Can Accelerate US Clinical Trials – Reducing Timelines Without Compromising Quality?

Explore how India is transforming the clinical trial landscape by enabling faster patient recruitment and streamlined execution—helping accelerate U.S. clinical trials without compromising quality or regulatory standards.

What You’ll Learn

• How India can significantly accelerate patient recruitment timelines

• Key considerations for maintaining global quality and compliance

• How to effectively integrate India into U.S. clinical development strategies

• Best practices for site selection and operational efficiency

• Real-world insights into executing trials across geographies

Why This Matters

• Increasing pressure to reduce clinical development timelines

• Need for diverse, scalable patient populations

• Balancing speed with quality in global trials

• Leveraging emerging markets for competitive advantage

Moderator

Dr. Melvin George

Chief Medical Officer - InoRx

Speakers

Dr. Shweta Shah

Medical Affairs Manager, Oncology
AstraZeneca

Join the live webinar and gain insights from our learning.